Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sanara Medtech Inc (SMTI)

Sanara Medtech Inc (SMTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sanara Medtech Inc 1200 Summit Avenue Suite 414 Fort Worth TX 76102 USA

www.sanaramedtech.com P: 817-529-2300

Description:

Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas.

Key Statistics

Overview:

Market Capitalization, $K 277,740
Enterprise Value, $K 282,280
Shares Outstanding, K 8,623
Annual Sales, $ 64,990 K
Annual Net Income, $ -4,300 K
Last Quarter Sales, $ 17,690 K
Last Quarter Net Income, $ -240 K
EBIT, $ -540 K
EBITDA, $ 3,140 K
60-Month Beta 1.57
% of Insider Shareholders 55.20%
% of Institutional Shareholders 8.10%
Float, K 3,863
% Float 44.80%
Short Volume Ratio 0.34

Growth:

1-Year Return -23.70%
3-Year Return 16.83%
5-Year Return 547.00%
5-Year Revenue Growth 1,012.84%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.03 on 03/25/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -0.58
EPS Growth vs. Prev Qtr 76.92%
EPS Growth vs. Prev Year 94.12%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 05/10/19

SMTI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -11.12%
Return-on-Assets % -7.11%
Profit Margin % -6.62%
Debt/Equity 0.22
Price/Sales 4.31
Price/Cash Flow N/A
Price/Book 6.24
Book Value/Share 5.22
Interest Coverage -8.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar